Cardiomyocyte-specific deletion of GCN5L1 in mice restricts mitochondrial protein hyperacetylation in response to a high fat diet.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
30 06 2020
Historique:
received: 13 01 2020
accepted: 15 06 2020
entrez: 2 7 2020
pubmed: 2 7 2020
medline: 15 12 2020
Statut: epublish

Résumé

Mitochondrial lysine acetylation regulates several metabolic pathways in cardiac cells. The current study investigated whether GCN5L1-mediated lysine acetylation regulates cardiac mitochondrial metabolic proteins in response to a high fat diet (HFD). GCN5L1 cardiac-specific knockout (cKO) mice showed significantly reduced mitochondrial protein acetylation following a HFD relative to wildtype (WT) mice. GCN5L1 cKO mice did not display any decrease in ex vivo cardiac workload in response to a HFD. In contrast, ex vivo cardiac function in HFD-fed WT mice dropped ~ 50% relative to low fat diet (LFD) fed controls. The acetylation status of electron transport chain Complex I protein NDUFB8 was significantly increased in WT mice fed a HFD, but remained unchanged in GCN5L1 cKO mice relative to LFD controls. Finally, we observed that inhibitory acetylation of superoxide dismutase 2 (SOD2) at K122 was increased in WT (but not cKO mice) on a HFD. This correlated with significantly increased cardiac lipid peroxidation in HFD-fed WT mice relative to GCN5L1 cKO animals under the same conditions. We conclude that increased GCN5L1 expression in response to a HFD promotes increased lysine acetylation, and that this may play a role in the development of reactive oxygen species (ROS) damage caused by nutrient excess.

Identifiants

pubmed: 32606301
doi: 10.1038/s41598-020-67812-x
pii: 10.1038/s41598-020-67812-x
pmc: PMC7326908
doi:

Substances chimiques

BLOC1S1 protein, mouse 0
Mitochondrial Proteins 0
Nerve Tissue Proteins 0
Reactive Oxygen Species 0
Superoxide Dismutase EC 1.15.1.1
superoxide dismutase 2 EC 1.15.1.1
Lysine K3Z4F929H6

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

10665

Subventions

Organisme : American Heart Association-American Stroke Association
ID : 17POST33670489
Pays : United States
Organisme : NHLBI NIH HHS
ID : R56 HL132917
Pays : United States
Organisme : NHLBI NIH HHS
ID : HL116728
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL132917
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL147861
Pays : United States
Organisme : NHLBI NIH HHS
ID : K99 HL146905
Pays : United States
Organisme : NHLBI NIH HHS
ID : K22 HL116728
Pays : United States
Organisme : NHLBI NIH HHS
ID : T32 HL110849
Pays : United States
Organisme : NHLBI NIH HHS
ID : HL110849
Pays : United States

Références

Alrob, O. A. et al. Obesity-induced lysine acetylation increases cardiac fatty acid oxidation and impairs insulin signalling. Cardiovasc. Res. 103, 485–497 (2014).
doi: 10.1093/cvr/cvu156
Hirschey, M. D. et al. SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature 464, 121–125 (2010).
doi: 10.1038/nature08778
Thapa, D. et al. The protein acetylase GCN5L1 modulates hepatic fatty acid oxidation activity via acetylation of the mitochondrial beta-oxidation enzyme HADHA. J. Biol. Chem. 293, 17676–17684 (2018).
doi: 10.1074/jbc.AC118.005462
Thapa, D. et al. Acetylation of mitochondrial proteins by GCN5L1 promotes enhanced fatty acid oxidation in the heart. Am. J. Physiol. Heart Circ. Physiol. 313, H265–H274 (2017).
doi: 10.1152/ajpheart.00752.2016
Scott, I., Webster, B. R., Li, J. H. & Sack, M. N. Identification of a molecular component of the mitochondrial acetyltransferase programme: a novel role for GCN5L1. Biochem. J. 443, 655–661 (2012).
doi: 10.1042/BJ20120118
Thapa, D. et al. Loss of GCN5L1 in cardiac cells limits mitochondrial respiratory capacity under hyperglycemic conditions. Physiol. Rep. 7, e14054 (2019).
doi: 10.14814/phy2.14054
Manning, J. R. et al. Loss of GCN5L1 in cardiac cells disrupts glucose metabolism and promotes cell death via reduced Akt/mTORC2 signaling. Biochem. J. 476, 1713–1724 (2019).
doi: 10.1042/BCJ20190302
Ahn, B. H. et al. A role for the mitochondrial deacetylase SIRT3 in regulating energy homeostasis. Proc. Natl. Acad. Sci. U. S. A. 105, 14447–14452 (2008).
doi: 10.1073/pnas.0803790105
Bao, J. et al. SIRT3 is regulated by nutrient excess and modulates hepatic susceptibility to lipotoxicity. Free Radic. Biol. Med. 49, 1230–1237 (2010).
doi: 10.1016/j.freeradbiomed.2010.07.009
Finley, L. W. et al. Succinate dehydrogenase is a direct target of sirtuin 3 deacetylase activity. PLoS ONE 6, e23295 (2011).
doi: 10.1371/journal.pone.0023295
Chouchani, E. T. et al. Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS. Nature 515, 431–435 (2014).
doi: 10.1038/nature13909
Karamanlidis, G. et al. Mitochondrial complex I deficiency increases protein acetylation and accelerates heart failure. Cell Metab. 18, 239–250 (2013).
doi: 10.1016/j.cmet.2013.07.002
Tao, R. et al. Sirt3-mediated deacetylation of evolutionarily conserved lysine 122 regulates MnSOD activity in response to stress. Mol. Cell 40, 893–904 (2010).
doi: 10.1016/j.molcel.2010.12.013
Hirschey, M. D. et al. SIRT3 deficiency and mitochondrial protein hyperacetylation accelerate the development of the metabolic syndrome. Mol. Cell 44, 177–190 (2011).
doi: 10.1016/j.molcel.2011.07.019
Kendrick, A. A. et al. Fatty liver is associated with reduced SIRT3 activity and mitochondrial protein hyperacetylation. Biochem. J. 433, 505–514 (2011).
doi: 10.1042/BJ20100791
Liu, Y., Fiskum, G. & Schubert, D. Generation of reactive oxygen species by the mitochondrial electron transport chain. J. Neurochem. 80, 780–787 (2002).
doi: 10.1046/j.0022-3042.2002.00744.x
McLennan, H. R. & Degli Esposti, M. The contribution of mitochondrial respiratory complexes to the production of reactive oxygen species. J. Bioenergy Biomembr. 32, 153–162 (2000).
doi: 10.1023/A:1005507913372
Turrens, J. F. & Boveris, A. Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria. Biochem. J. 191, 421–427 (1980).
doi: 10.1042/bj1910421
Vazquez, E. J. et al. Mitochondrial complex I defect and increased fatty acid oxidation enhance protein lysine acetylation in the diabetic heart. Cardiovasc. Res. 107, 453–465 (2015).
doi: 10.1093/cvr/cvv183
Oberley, L. W. & Oberley, T. D. Role of antioxidant enzymes in cell immortalization and transformation. Mol. Cell Biochem. 84, 147–153 (1988).
doi: 10.1007/BF00421049
Manning, J. R. et al. Cardiac-specific deletion of GCN5L1 restricts recovery from ischemia-reperfusion injury. J. Mol. Cell Cardiol. 129, 69–78 (2019).
doi: 10.1016/j.yjmcc.2019.02.009

Auteurs

Dharendra Thapa (D)

Vascular Medicine Institute, University of Pittsburgh, Pittsburgh, PA, 15261, USA.
Center for Metabolism, University of Pittsburgh, Pittsburgh, PA, 15261, USA.
Division of Cardiology, Department of Medicine, University of Pittsburgh, BST E1256, 200 Lothrop Street, Pittsburgh, PA, 15261, USA.

Janet R Manning (JR)

Vascular Medicine Institute, University of Pittsburgh, Pittsburgh, PA, 15261, USA.
Center for Metabolism, University of Pittsburgh, Pittsburgh, PA, 15261, USA.
Division of Cardiology, Department of Medicine, University of Pittsburgh, BST E1256, 200 Lothrop Street, Pittsburgh, PA, 15261, USA.

Michael W Stoner (MW)

Vascular Medicine Institute, University of Pittsburgh, Pittsburgh, PA, 15261, USA.
Center for Metabolism, University of Pittsburgh, Pittsburgh, PA, 15261, USA.
Division of Cardiology, Department of Medicine, University of Pittsburgh, BST E1256, 200 Lothrop Street, Pittsburgh, PA, 15261, USA.

Manling Zhang (M)

Vascular Medicine Institute, University of Pittsburgh, Pittsburgh, PA, 15261, USA.
Center for Metabolism, University of Pittsburgh, Pittsburgh, PA, 15261, USA.
Division of Cardiology, Department of Medicine, University of Pittsburgh, BST E1256, 200 Lothrop Street, Pittsburgh, PA, 15261, USA.

Bingxian Xie (B)

Vascular Medicine Institute, University of Pittsburgh, Pittsburgh, PA, 15261, USA.
Center for Metabolism, University of Pittsburgh, Pittsburgh, PA, 15261, USA.
Division of Cardiology, Department of Medicine, University of Pittsburgh, BST E1256, 200 Lothrop Street, Pittsburgh, PA, 15261, USA.

Iain Scott (I)

Vascular Medicine Institute, University of Pittsburgh, Pittsburgh, PA, 15261, USA. iain.scott@pitt.edu.
Center for Metabolism, University of Pittsburgh, Pittsburgh, PA, 15261, USA. iain.scott@pitt.edu.
Division of Cardiology, Department of Medicine, University of Pittsburgh, BST E1256, 200 Lothrop Street, Pittsburgh, PA, 15261, USA. iain.scott@pitt.edu.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH